Guy S et al. |
Immunosuppression conversion for relief of side effects. |
1994 |
Transplant. Proc. |
pmid:7527956
|
Knoop C et al. |
FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases. |
1994 |
Transplant. Proc. |
pmid:7527957
|
Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|
|
Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group. |
1994 |
Transplant. Proc. |
pmid:7527960
|
Nomoto S et al. |
Cardiotoxicity of long-term intravenous administration of FK506 in rabbits: dose relationship and recovery after discontinuance. |
1994 |
Transplant. Proc. |
pmid:7513477
|
Kato H et al. |
Spontaneous proliferation of peripheral blood mononuclear cells as an indicator for insufficient plasma levels of FK 506 in the early phase after liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7513481
|
Nishikawa K et al. |
Experimental studies of vascularized joint allografts in rats. |
1994 |
Transplant. Proc. |
pmid:7513482
|
Fukuzawa M and Okada A |
Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection. |
1994 |
Transplant. Proc. |
pmid:7513483
|
Bennett WM et al. |
Nephrotoxicity of immunosuppressive drugs. |
1994 |
Miner Electrolyte Metab |
pmid:7531274
|
Sekigawa I et al. |
FK506 can inhibit apoptotic cell death induced by the HIV-1 envelope glycoprotein gp120. |
1994 |
AIDS |
pmid:7531458
|
Kraus-Friedmann N and Feng L |
Reduction of ryanodine binding and cytosolic Ca2+ levels in liver by the immunosuppressant FK506. |
1994 |
Biochem. Pharmacol. |
pmid:7529023
|
Cardenas ME et al. |
Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. |
1994 |
EMBO J. |
pmid:7529175
|
Hisatomi K et al. |
Limited effectiveness of FK506 administration for ongoing rejection in heterotopic rat heart transplantation. |
1994 |
Surg. Today |
pmid:7516210
|
Burkhalter EL et al. |
Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. |
1994 |
J. Hepatol. |
pmid:7529272
|
Kawano K et al. |
Evidence that FK506 alleviates ischemia/reperfusion injury to the rat liver: in vivo demonstration for suppression of TNF-a production in response to endotoxemia. |
1994 |
Eur Surg Res |
pmid:7516291
|
Hashimoto T et al. |
Treatment with FK506 prevents rejection of rat colon allografts. |
1994 |
Transplantation |
pmid:7516586
|
Todo S et al. |
Intestinal transplantation at the University of Pittsburgh. |
1994 |
Transplant. Proc. |
pmid:7518136
|
Reyes J et al. |
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7518137
|
Murase N et al. |
Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. |
1994 |
Transplant. Proc. |
pmid:7518139
|
Fujisaki S et al. |
Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518140
|
Platz KP et al. |
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518975
|
Cakaloglu Y et al. |
Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients. |
1994 |
Hepatology |
pmid:7519161
|
Luan S et al. |
Light-regulated, tissue-specific immunophilins in a higher plant. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7508125
|
Blazar BR et al. |
FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation. |
1994 |
J. Immunol. |
pmid:7519216
|
Laifer SA et al. |
Pregnancy after cardiac transplantation. |
1994 |
Am J Perinatol |
pmid:7519426
|
Yamauchi T |
[Multiple abdominal organ transplantation in swine using FK-506]. |
1994 |
Nihon Geka Gakkai Zasshi |
pmid:7510015
|
Nozaki S et al. |
Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. |
1994 |
Transplant. Proc. |
pmid:7520633
|
Masaoka T |
Problems of bone marrow transplantation in Japan. |
1994 |
Transplant. Proc. |
pmid:7520634
|
Okano K et al. |
Ameliorative effect of FK 506 on cold ischemia reperfusion injury of the rat liver. |
1994 |
Transplant. Proc. |
pmid:7520635
|
Meadows RP et al. |
A computer-based protocol for semiautomated assignments and 3D structure determination of proteins. |
1994 |
J. Biomol. NMR |
pmid:7510556
|
Metcalfe S et al. |
FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. |
1994 |
Cell. Immunol. |
pmid:7522130
|
Nichols RA et al. |
Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. |
1994 |
J. Biol. Chem. |
pmid:7522234
|
Calne RY |
Immunosuppression in liver transplantation. |
1994 |
N. Engl. J. Med. |
pmid:7523947
|
Schleuning M et al. |
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives. |
1994 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:7523957
|
Perotti BY et al. |
HPLC assay for FK 506 and two metabolites in isolated rat hepatocytes and rat liver microsomes. |
1994 |
Pharm. Res. |
pmid:7524055
|
|
FDA approved new drug bulletin: aprotinin injection (trasylol), tacrolimus (prograf). |
1994 |
RN |
pmid:7524131
|
Connolly JO et al. |
Renal arteriopathy associated with FK 506 therapy following liver transplantation. |
1994 |
Nephrol. Dial. Transplant. |
pmid:7526278
|
Pham SM et al. |
Cardiac transplantation at the University of Pittsburgh: 1994 update. |
1994 |
Clin Transpl |
pmid:7547531
|
Radanyi C et al. |
The ability of the immunophilin FKBP59-HBI to interact with the 90-kDa heat shock protein is encoded by its tetratricopeptide repeat domain. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7526392
|
Abu-Elmagd K et al. |
Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. |
1994 |
Clin Transpl |
pmid:7547533
|
Ko S et al. |
The pharmacokinetic benefits of newly developed liposome-incorporated FK506. |
1994 |
Transplantation |
pmid:7526494
|
Shapiro R et al. |
Renal transplantation at the University of Pittsburgh: the impact of FK506. |
1994 |
Clin Transpl |
pmid:7547544
|
Holländer GA et al. |
Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo. |
1994 |
Transplantation |
pmid:7526495
|
Chavin KD et al. |
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. |
1994 |
Transplantation |
pmid:7511258
|
Yano S et al. |
Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes. |
1994 |
Jpn. J. Cancer Res. |
pmid:7511575
|
Iwata H et al. |
Suppression of allograft responses by combining alloantigen-specific i.v. pre-sensitization with suboptimal doses of rapamycin. |
1994 |
Int. Immunol. |
pmid:7511931
|
Mayrleitner M et al. |
The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptor. |
1994 |
Cell Calcium |
pmid:7511990
|
Metcalfe S et al. |
FK 506 and cyclosporin each block antigen-induced T cell receptor signalling that is dependent on CD4 co-receptor and operates in the absence of detectable cytoplasmic calcium fluxes. |
1994 |
Transpl. Int. |
pmid:11271304
|
Moutabarrik A et al. |
Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes. |
1994 |
Transpl. Int. |
pmid:11271305
|
Winkler M et al. |
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271312
|